BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2729409)

  • 21. Epidemiologic aspects of uveal melanoma.
    Egan KM; Seddon JM; Glynn RJ; Gragoudas ES; Albert DM
    Surv Ophthalmol; 1988; 32(4):239-51. PubMed ID: 3279559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous dysplastic naevi: risk factor for uveal melanoma.
    Hammer H; Tóth-Molńar E; Oláh J; Dobozy A
    Lancet; 1995 Jul; 346(8969):255-6. PubMed ID: 7616832
    [No Abstract]   [Full Text] [Related]  

  • 23. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80.
    Osterlind A; Olsen JH; Lynge E; Ewertz M
    Natl Cancer Inst Monogr; 1985 Dec; 68():361-88. PubMed ID: 4088310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological trends in uveal melanoma.
    Andreoli MT; Mieler WF; Leiderman YI
    Br J Ophthalmol; 2015 Nov; 99(11):1550-3. PubMed ID: 25904122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uveal melanoma-associated cancers revisited.
    Alfaar AS; Saad A; Elzouki S; Abdel-Rahman MH; Strauss O; Rehak M
    ESMO Open; 2020 Nov; 5(6):e000990. PubMed ID: 33257317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple neoplasms in patients with uveal melanoma: a systematic review.
    de Esteban Maciñeira E; Fernández Fernández P; Conde González I; Bande Rodríguez MF; Blanco Teijeiro MJ
    Int Ophthalmol; 2024 Jun; 44(1):256. PubMed ID: 38909111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers.
    Dong C; Hemminki K
    Int J Cancer; 2001 Jun; 92(6):883-7. PubMed ID: 11351311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification.
    Stang A; Parkin DM; Ferlay J; Jöckel KH
    Int J Cancer; 2005 Mar; 114(1):114-23. PubMed ID: 15523698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of uveal melanoma in Europe.
    Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
    Ophthalmology; 2007 Dec; 114(12):2309-15. PubMed ID: 17498805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implication of ultraviolet light in the etiology of uveal melanoma: A review.
    Mallet JD; Gendron SP; Drigeard Desgarnier MC; Rochette PJ
    Photochem Photobiol; 2014 Jan; 90(1):15-21. PubMed ID: 23981010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bilateral uveal melanomas. Five case reports].
    Bhouri L; Lumbroso L; Levy C; Dendale R; Asselain B; Plancher C; Sastre X; Desjardins L
    J Fr Ophtalmol; 2003 Feb; 26(2):149-53. PubMed ID: 12660588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of fluorescence in situ hybridization to distinguish metastatic uveal from cutaneous melanoma.
    Fang Y; Wang X; Dusza S; Jhanwar S; Abramson D; Busam KJ
    Int J Surg Pathol; 2012 Jun; 20(3):246-51. PubMed ID: 22415057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
    Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
    Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased risk of subsequent primary noncutaneous malignancies among patients with primary cutaneous malignant melanoma.
    Wagner RF; Pellegrini JR; Delzell E
    J Dermatol Surg Oncol; 1985 Nov; 11(11):1097-102. PubMed ID: 4056192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Connection between uveal melanoma and dysplastic naevus syndrome].
    Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
    Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis.
    Kuk D; Shoushtari AN; Barker CA; Panageas KS; Munhoz RR; Momtaz P; Ariyan CE; Brady MS; Coit DG; Bogatch K; Callahan MK; Wolchok JD; Carvajal RD; Postow MA
    Oncologist; 2016 Jul; 21(7):848-54. PubMed ID: 27286787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation.
    Holfort SK; Lindegaard J; Isager P; Prause JU; Heegaard S
    Br J Ophthalmol; 2009 May; 93(5):641-4. PubMed ID: 19091854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis.
    Singh AD; De Potter P; Fijal BA; Shields CL; Shields JA; Elston RC
    Ophthalmology; 1998 Jan; 105(1):195-8. PubMed ID: 9442799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of uveal melanoma in the United States: 1973-1997.
    Singh AD; Topham A
    Ophthalmology; 2003 May; 110(5):956-61. PubMed ID: 12750097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.